Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–19 of 19 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
NCT05710848
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- East Valley Urology Center of Arizona Mesa, Arizona, United States
- Arizona Urology Specialists Tucson, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Unio Specialty Care - A Genesis Healthcare Partners Facility Bakersfield, California, United States
Recruiting
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
NCT05796375
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- West Haven VA Medical Center West Haven, Connecticut, United States
- Bay Pines VA Healthcare System Bay Pines, Florida, United States
- James A. Haley Veterans' Hospital Tampa, Florida, United States
- VA Boston Jamaica Plains Campus West Roxbury, Massachusetts, United States
Recruiting
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
NCT05002556
- Conditions
- Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
- Locations
-
- Hopital Prive de Provence Aix-en-Provence, France
- CHU Angers Angers, France
- Hopital Privé Arras les Bonnettes Arras, France
- Centre hospitalier Privé Montgradé Aubergenville, France
NCT05483868
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Arkansas Urology Little Rock, Arkansas, United States
- Tower Urology Los Angeles, California, United States
- Saint John's Cancer Institute Santa Monica, California, United States
- Montefiore Medical Center The Bronx, New York, United States
NCT07494864
- Conditions
- Acute Catheter-associated UTI (CAUTI), Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying, Asymptomatic Bacteriuria in Subjects Relying on Some Type of Catheter, +20 more
- Locations
-
- Balgrist University Hospital Zurich, Canton of Zurich, Switzerland
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
- Locations
-
- AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy Rome, Lazio, Italy
Recruiting
A Phase I Intravesical PPM Therapy for NMIBC
NCT05519241
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston, Massachusetts, United States
NCT05825950
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
NCT06972771
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Yunnan Cancer Hospital Kunming, Yunnan, China
NCT05790850
- Conditions
- Behavior, Bladder Cancer, Carcinoma, +17 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT05232136
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
Not Yet Recruiting
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
NCT07189793
- Conditions
- Carcinoma, Carcinoma in Situ, Carcinoma in Situ of Bladder, +16 more
- Locations
-
- The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
Not Yet Recruiting
T-Control® Safety for Cytostatics Management
NCT06678633
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
Not Yet Recruiting
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
NCT06327932
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
NCT03664258
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University Clinic for Urology and Andrology Salzburg, Austria
- Medical University of Vienna Vienna, Austria
- Teaching Hospital Motol Prague, Czechia
- CHU Toulouse / Institut Universitaire du Cancer Toulouse Oncopole Toulouse, France
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +28 more
- Locations
-
- Themistoklis Bellos Marathon, Attica, Greece
Active, Not Recruiting
Intravesical BCG vs GEMDOCE in NMIBC
NCT05538663
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
Active, Not Recruiting
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer
NCT03528694
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Research Site Auchenflower, Australia
- Research Site Box Hill, Australia
- Research Site Brisbane, Australia
- Research Site Kogarah, Australia
Active, Not Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552
- Conditions
- Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- UMass Memorial Medical Center Worchester, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
- Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States